Skip to main content

4Front Ventures Corp.

FFNTFDelisted
Industry
Medicinal Chemicals & Botanical Products
SEC CIK
0001783875

4Front Ventures Corp. was delisted in 2026; its insiders filed their last Form 4 on May 19, 2025; no institution reported holding it in 13F filings for Q2 2026; no superinvestor held it.

Key figures

Insider buys
0
Open market, last 90 days
Insider sells
0
Open market, last 90 days
13F holders
0
Q2 2026
13F value
$0
Reported value at the end of Q2 2026
Superinvestors holding
0
At the end of Q2 2026

Superinvestors holding FFNTF, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding FFNTF at the end of Q2 2026.

Latest insider trades

Open-market purchases and sales by 4Front Ventures Corp. insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 8, 2023 (view filing)2:17 PM ETSep 6-72 daysGontmakher LeonidChief Executive OfficerPPurchaseClass A Subordinate Voting Shares+95.0K$0.2278+$21.6K+0.2%41.5M after2 lots
Aug 30, 2023 (view filing)3:54 PM ETAug 291 dayGontmakher LeonidChief Executive OfficerPPurchaseClass A Subordinate Voting Shares+14.5K$0.125+$1.81K0.0%32.1M after
Nov 14, 2022 (view filing)Jun 17150 daysAdams Keith EdwardChief Financial OfficerSSaleClass A Subordinate Voting Shares+1.00M$0.00$0–1.00M afterAmendedDerivative
Jun 21, 2022 (view filing)Jun 174 daysGulati ChetanDirectorSSaleClass A Subordinate Voting Shares−7.50K$0.63−$4.72K0.0%23.8M after
Jun 17, 2022 (view filing)Jun 152 daysGulati ChetanDirectorSSaleClass A Subordinate Voting Shares−500$0.66−$3300.0%23.8M after
Jun 15, 2022 (view filing)Jun 13-142 daysGulati ChetanDirectorSSaleClass A Subordinate Voting Shares−169.0K$0.6699−$113.2K−0.7%23.8M after2 lots
Jun 13, 2022 (view filing)Jun 103 daysGulati ChetanDirectorSSaleClass A Subordinate Voting Shares−300.0K$0.68−$204.0K−1.2%24.0M after
Jun 8, 2022 (view filing)Jun 62 daysGulati ChetanDirectorSSaleClass A Subordinate Voting Shares−47.0K$0.72−$33.8K−0.2%27.2M after
Oct 8, 2021 (view filing)Oct 62 daysGulati ChetanDirectorPPurchaseClass A Subordinate Voting Shares+9.71M$8,237,536.22+$80.0T–9.03M afterDerivative2 lotsPrice outlier

Top 10 13F holders, Q2 2026

The largest institutional positions in 4Front Ventures Corp. at the end of Q2 2026; share changes are against Q1 2026.

View all: Top 10 13F holders, Q2 2026

No institution reported holding FFNTF in 13F filings for Q2 2026.